Clinical Impact Through AI-assisted MS Care - A Retrospective Multi-center Observational Study.
Abroad (travel likely)Recruiting
Conditions
Multiple Sclerosis · NMO Spectrum Disorder · Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease · Radiologically Isolated Syndrome · Clinically Isolated Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
General University Hospital Prague, Prague, Praha 2, Czechia
Contact: Study coordinator (Dana Horakova, Doc. MUDr., PhD)Katholisches Klinikum Bochum - St. Joseph-Hospital, Bochum, Bochum, Germany
Contact: Study coordinator (Carsten Lukas, Prof. Dr. med.)ERC Charité - Universitätsmedizin Berlin, Berlin, State of Berlin, Germany
Contact: Study coordinator (Tanja Schmitz-Hübsch, PD Dr.)
Study leads
Friedemann Paul, PhD, MD
Principal Investigator
Max Delbrück Center - Charite University, Berlin, Germany